Statistics
Publications
4
Citations
465
H-Index
4
Active since
2003
Affiliations
PDL BioPharma (United States)(Current)
Rick Powers is an author at PDL BioPharma (United States) specializing in oncology, cancer pharmacology, and pharmacology.
Publications per year
2003–2018
4
4
Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.
Vanitha Ramakrishnan, Vinay Bhaskar, Debbie A. Law et al. · PubMed · 2006 · 116 citations
Pharmacy, Oncology, Pharmacology +17
E-selectin up-regulation allows for targeted drug delivery in prostate cancer.
Vinay Bhaskar, Debbie A. Law, Eric Ibsen et al. · PubMed · 2003 · 65 citations
Medicine, Oncology, Pharmacology +15
1–4 of 4